Riskpilot← Back to searchSign inGet full accessBIOVITA A/S
A/SActiveCVR 82590013Gotlandsvej 16AWholesale of pharmaceutical and medical goods · NACE 4646Est. 19773 employees
Revenue 2025
DKK 2,8M
-12% vs 2024
EBITDA margin
37.6%
-10% vs 2024
Equity ratio
68.1%
Financial strength
Net profit 2025
DKK 781K
-16% vs 2024
| Revenue | DKK 2,8M | -12% |
| EBITDA | DKK 1,1M | -10% |
| Net profit | DKK 781K | -16% |
| Total assets | DKK 6,1M | +8% |
| Equity | DKK 4,1M | +23% |
| Employees | 3 | — |
Legal name
BIOVITA A/S
CVR number
82590013
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
5. august 1977
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af to medlemmer af bestyrelsen i forening.
Company purpose
Selskabets formål er at drive virksomhed med handel af enhver art, herunder im- og export, opstilling og indkøring af leverede maskiner og anlæg.
Address
Gotlandsvej 16A
Phone
+4576260766
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.672 | 2.421 | 2.878 | 3.235 | 2.845 |
| Staff expenses | -1.640 | -1.861 | -1.889 | -2.048 | -1.775 |
| EBITDA | 1.032 | 560 | 989 | 1.187 | 1.070 |
| Depreciation & amort. | -101 | -0 | -0 | -0 | -28 |
| EBIT | 932 | 560 | 989 | 1.187 | 1.042 |
| Net financials | -78 | -31 | -47 | -6 | -40 |
| Profit before tax | 854 | 529 | 942 | 1.181 | 1.002 |
| Tax | 188 | 127 | 203 | 254 | 221 |
| Net profit | 665 | 402 | 739 | 927 | 781 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8.064 | 4.060 | 4.669 | 5.599 | 6.060 |
| Equity | 4.633 | 2.883 | 3.422 | 3.349 | 4.130 |
| Long-term debt | 1.359 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.594 | 1.178 | 1.247 | 2.250 | 1.920 |
| Total debt | 2.953 | 1.178 | 1.247 | 2.250 | 1.920 |
EBITDA margin
37.6%
This company
15.8%
Market median
+138% vs market
20212025
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20212025
Return on equity
18.9%
This company
18.4%
Market median
+3% vs market
20212025
Net profit margin
27.5%
This company
8.1%
Market median
+240% vs market
20212025
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TK Management | Management | 2001 |
| Former (5) | ||
HG Management | Management | 2006 – 2009 |
| Audit | 2005 – 2008 | |
P | Audit | 1993 – 2005 |
WK Management | Management | 1977 – 2001 |
CC Audit | Audit | 1977 – 1992 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2008 | |
| Board of Directors | 2005 | |
| Former (2) | ||
| Board of Directors | 1977 – 2004 | |
| Chairman | 2005 – 2008 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
W. KJÆRSGAARD HOLDING ApS
BIOVITA A/S Board members of BIOVITA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henriette Geer | Management | 0 companies |
| Qurios Statsautoriseret Revisionsinteressentskab | Audit | 0 companies |
| PricewaterhouseCoopers | Audit | 0 companies |
| Thomas Kjærsgaard | Management | 0 companies |
| Werner Kjærsgaard | Management | 0 companies |
| Carl-Erik Carlsen | Audit | 0 companies |
| Michael Bach Jensen | Chairman | 0 companies |
| Astrid Kjærsgaard | Board of Directors | 0 companies |
| Klaus Rene Rasmussen | Board of Directors | 0 companies |
| Ole Møller Jespersen | Chairman | 0 companies |